Genmab Logo

Genmab

GMAB | CO

Overview

Corporate Details

ISIN(s):
DK0010272202 (+2 more)
LEI:
529900MTJPDPE4MHJ122
Country:
Denmark
Address:
Carl Jacobsens Vej 30, 2500 Valby
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer and other serious diseases. The company leverages its proprietary antibody technology platforms to pioneer and develop next-generation treatments. Through a combination of strategic partnerships and an expanding in-house pipeline, Genmab has successfully contributed to multiple approved medicines, focusing on transforming patient outcomes with its innovative science.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Genmab. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-12 20:36
Share Issue/Capital Change
English 175.2 KB
2025-08-12 20:36
Share Issue/Capital Change
English 7.8 KB
2025-08-07 17:08
Earnings Release
English 17.2 KB
2025-08-07 17:08
Earnings Release
English 741.7 KB
2025-08-07 16:30
Regulatory News Service
English 207.6 KB
2025-08-07 16:30
Legal Proceedings Report
English 21.0 KB
2025-07-16 12:29
Regulatory News Service
English 212.2 KB
2025-07-16 12:29
Earnings Release
English 7.7 KB
2025-06-30 15:29
Transaction in Own Shares
English 202.2 KB
2025-06-30 15:29
Transaction in Own Shares
English 1.4 MB
2025-06-30 15:29
Transaction in Own Shares
English 21.9 KB
2025-06-23 14:19
Director's Dealing
English 120.4 KB
2025-06-23 14:19
Transaction in Own Shares
English 167.5 KB
2025-06-23 14:19
Transaction in Own Shares
English 23.5 KB
2025-06-18 09:34
Share Issue/Capital Change
English 7.8 KB

Automate Your Workflow. Get a real-time feed of all Genmab filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Genmab via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
VERICI DX PLC Logo
AI-powered diagnostic tests for the kidney transplant market, predicting organ rejection and injury.
United Kingdom VRCI
Vicore Pharma Holding Logo
Develops AT2 receptor drugs and a digital therapeutic for pulmonary fibrosis.
Sweden VICO
Vivoryon Therapeutics N.V. Logo
Develops small molecule therapies for severe age-related, inflammatory, and neurodegenerative diseases.
Germany VVY
R&D in renewable energy & manufacturing specialized tools for automotive & engineering.
Slovakia N/A
Xintela AB Logo
Develops stem cell therapies and targeted antibody treatments for cancer and osteoarthritis.
Sweden XINT
Xlife Sciences AG Logo
A life sciences incubator commercializing early-stage academic research for healthcare markets.
Switzerland XLS
XTL Biopharmaceuticals Ltd. Logo
Acquires and develops late-stage therapeutics for autoimmune diseases.
Israel XTLB
Yoshi Innovation Spolka Akcyjna Logo
A tech fund incubating MedTech, biotech, and defense ventures with investment and IP protection.
Poland YOS
Zealand Pharma Logo
Develops innovative peptide medicines for metabolic and rare diseases.
Denmark ZEAL
Ziccum AB Logo
Licenses drying tech for thermostable vaccines & biologics, eliminating the cold chain.
Sweden ZICC